Central nervous system infections in immunocompromised patients – update on diagnostics and therapy
- 1 January 2009
- journal article
- review article
- Published by Informa UK Limited in Leukemia & Lymphoma
- Vol. 50 (1), 24-36
- https://doi.org/10.1080/10428190802517740
Abstract
Infections of the central nervous system (CNS) are increasingly reported in patients with malignancies. Heavily immunocompromised patients like those after allogeneic stem cell transplantation (SCT) or previous T cell depleting treatment regimens (e.g. with fludarabine or alemtuzumab) are at highest risk for cerebral infections. The spectrum of causative organisms may vary greatly, depending on the underlying malignancy, its treatment and various other factors. Toxoplasma gondii and fungi are the leading causative organisms in patients after allogeneic SCT, but also viruses such as herpes simplex virus or JC virus may be detected in these patients. Definitive diagnosis of cerebral infection still remains a high challenge, although diagnostics have improved by the wide availability of imaging techniques and polymerase chain reaction in recent years. Novel therapeutic options are arising, particularly for fungal CNS infections. Here, we summarise aspects on epidemiology, clinical symptoms and prognosis of CNS infections in patients with malignancies. Additionally, we give an overview on the diagnostics and management of cerebral infections in these patients including evidence evaluation of efficacy of treatment.Keywords
This publication has 110 references indexed in Scilit:
- Steroids for Deteriorating Herpes Simplex Virus EncephalitisPediatric Neurology, 2007
- New Guinea Pig Model of Cryptococcal MeningitisAntimicrobial Agents and Chemotherapy, 2007
- Identification of Genotypically Diverse Cryptococcus neoformans and Cryptococcus gattii Isolates by Luminex xMAP TechnologyJournal of Clinical Microbiology, 2007
- In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the EtestAntimicrobial Agents and Chemotherapy, 2007
- Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular TaxonomyClinical Microbiology Reviews, 2006
- Parasitic Central Nervous System Infections in Immunocompromised Hosts: Malaria, Microsporidiosis, Leishmaniasis, and African TrypanosomiasisClinical Infectious Diseases, 2006
- Brain abscess: clinical experience and analysis of prognostic factorsSurgical Neurology, 2005
- Guide to Development of Practice GuidelinesClinical Infectious Diseases, 2001
- Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspirationSurgical Neurology, 1987
- Vidarabine versus Acyclovir Therapy in Herpes Simplex EncephalitisNew England Journal of Medicine, 1986